| Jennifer Bell, MD | |
|
33 Bartlett St, Lowell, MA 01852-1334 | |
| (978) 452-2200 | |
| Not Available |
| Full Name | Jennifer Bell |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 33 Bartlett St, Lowell, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336106657 | NPI | - | NPPES |
| 987927 | Other | MA | NETWORK HEALTH |
| J23128 | Other | MA | BLUE CROSS/BLUE SHIELD |
| 202338 | Other | MA | HARVARD PILGRIM |
| MB0408270A | Other | MA | MA CONTROLLE SUBSTANCE |
| 7864422 | Other | MA | AETNA US HEALTHCARE |
| 205676 | Other | MA | MA LICENSE |
| 0151271 | Medicaid | MA | |
| 205676 | Other | MA | TUFTS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 205676 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Bell, MD 33 Bartlett St, Lowell, MA 01852-1334 Ph: (978) 452-2200 | Jennifer Bell, MD 33 Bartlett St, Lowell, MA 01852-1334 Ph: (978) 452-2200 |
News Archive
"An outbreak of polio in three children from the south of Madagascar has raised concerns over a possible resurgence of this crippling disease," BBC News reports, adding, "UNICEF spokesman Daniel Timme says three cases of polio without symptoms have been identified ... during UNICEF's Mother and Child Health week following tests and urine samples".
An upgrade in The University of Queensland's artificial intelligence capabilities could help to revolutionise pathology laboratories across Australia.
Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for OFIRMEV™ (acetaminophen) injection, the first and only intravenous (IV) formulation of acetaminophen to be approved in the United States. OFIRMEV is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.
Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.
A study presented at this year's American Society of Anesthesiologists (ASA) Annual Meeting demonstrated that the use of the sedative Dexmedetomidine was safe and reduced the amount of time for the extubation process, or the process of removing a tube from the airway of critically ill patients.
› Verified 6 days ago
Daniel W Dubner, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 33 Bartlett St, Lowell, MA 01852 Phone: 978-452-2200 | |
Dr. Suparna Sharma, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6000 | |
Wesley Dean, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 161 Jackson St, Lowell, MA 01852 Phone: 978-937-9700 | |
Mr. Stephen A Conway, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 33 Bartlett St, Suite 305, Lowell, MA 01852 Phone: 978-452-2200 Fax: 978-441-2651 | |
Cathleen Bonacci, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 597 Merrimack St, Lowell Community Health Center, Lowell, MA 01854 Phone: 978-937-9700 Fax: 978-446-9830 | |
Purnima Baranwal, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 597 Merrimack St, Lowell, MA 01854 Phone: 978-937-9700 | |
Dr. Kristen A Klemmer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6000 |